Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1996 3
1997 5
1998 3
1999 2
2000 1
2001 5
2002 3
2003 4
2004 3
2005 1
2006 2
2007 2
2008 2
2009 6
2010 2
2011 11
2012 8
2013 11
2014 10
2015 17
2016 11
2017 12
2018 15
2019 17
2020 16
2021 11
2022 19
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

171 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study.
Wray S, Then Bergh F, Wundes A, Arnold DL, Drulovic J, Jasinska E, Bowen JD, Negroski D, Naismith RT, Hunter SF, Gudesblatt M, Chen H, Lyons J, Shankar SL, Kapadia S, Mendoza JP, Singer BA. Wray S, et al. Among authors: drulovic j. Adv Ther. 2022 Apr;39(4):1810-1831. doi: 10.1007/s12325-022-02068-7. Epub 2022 Feb 24. Adv Ther. 2022. PMID: 35211872 Free PMC article. Clinical Trial.
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study.
Filippi M, Preziosa P, Meani A, Dalla Costa G, Mesaros S, Drulovic J, Ivanovic J, Rovira A, Tintorè M, Montalban X, Ciccarelli O, Brownlee W, Miszkiel K, Enzinger C, Khalil M, Barkhof F, Strijbis EMM, Frederiksen JL, Cramer SP, Fainardi E, Amato MP, Gasperini C, Ruggieri S, Martinelli V, Comi G, Rocca MA; MAGNIMS Study Group. Filippi M, et al. Among authors: drulovic j. Neurology. 2022 Jan 4;98(1):e1-e14. doi: 10.1212/WNL.0000000000013016. Epub 2021 Oct 29. Neurology. 2022. PMID: 34716250
Managing MS in a changing treatment landscape.
Duddy M, Haghikia A, Cocco E, Eggers C, Drulovic J, Carmona O, Zéphir H, Gold R. Duddy M, et al. Among authors: drulovic j. J Neurol. 2011 May;258(5):728-39. doi: 10.1007/s00415-011-6009-x. Epub 2011 Mar 25. J Neurol. 2011. PMID: 21437661 Review.
The epidemiology of multiple sclerosis in Europe.
Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vécsei L, Milanov I. Pugliatti M, et al. Among authors: drulovic j. Eur J Neurol. 2006 Jul;13(7):700-22. doi: 10.1111/j.1468-1331.2006.01342.x. Eur J Neurol. 2006. PMID: 16834700 Free article. Review.
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis.
De Vito F, Musella A, Fresegna D, Rizzo FR, Gentile A, Stampanoni Bassi M, Gilio L, Buttari F, Procaccini C, Colamatteo A, Bullitta S, Guadalupi L, Caioli S, Vanni V, Balletta S, Sanna K, Bruno A, Dolcetti E, Furlan R, Finardi A, Licursi V, Drulovic J, Pekmezovic T, Fusco C, Bruzzaniti S, Hornstein E, Uccelli A, Salvetti M, Matarese G, Centonze D, Mandolesi G. De Vito F, et al. Among authors: drulovic j. Neuropathol Appl Neurobiol. 2022 Feb;48(2):e12765. doi: 10.1111/nan.12765. Epub 2021 Oct 6. Neuropathol Appl Neurobiol. 2022. PMID: 34490928 Free PMC article.
Sudomotor dysfunction in people with neuromyelitis optica spectrum disorders.
Habek M, Andabaka M, Fanciulli A, Brecl Jakob G, Drulović J, Leys F, Di Pauli F, Hegen H, Auer M, Pekmezović T, Mesaroš Š, Jovičević V, Junaković A, Wenning GK, Deisenhammer F, Gabelić T, Barun B, Adamec I, Krbot Skorić M. Habek M, et al. Among authors: drulovic j. Eur J Neurol. 2022 Sep;29(9):2772-2780. doi: 10.1111/ene.15413. Epub 2022 Jun 12. Eur J Neurol. 2022. PMID: 35598288
171 results